mpox
Co-Circulating Viruses Causing Concern in Mpox Outbreak
Surveillance in Uganda has found co-circulating viruses, particularly varicella-zoster virus and mpox, with one ...
MARCH 13, 2025
Although Safe, Tecovirimat Proves Ineffective for Treating Clade II Mpox
More data from the STOMP trial presented at CROI 2025, held in San Francisco, confirms that tecovirimat does not ...
MARCH 13, 2025
California Confirms First Clade I Mpox Case
The California Department of Public Health reported the first known case of clade I mpox in the United States. The ...
NOVEMBER 19, 2024
Previous Smallpox Vaccination Boosts Immunogenicity of Mpox Vaccine
Immunogenicity after mpox vaccination lasted longer among people who had received a smallpox vaccination as a child ...
MAY 2, 2024
ACIP Recommends Jynneos Vaccine for Certain Populations
ACIP recommended the 2-dose Jynneos vaccine series for adults at risk for mpox to increase vaccination and reduce ...
OCTOBER 26, 2023
Lesions Following TPOXX Mpox Treatment
A small number of patients who were treated for mpox with TPOXX have developed new skin or mucosal lesions ...
JULY 11, 2023
Mpox Cases Rise, Offering Reminder That Outbreak Continues
Although mpox cases have declined since, reports of continued community transmission in the United States and ...
MAY 18, 2023
Mpox and Severe HIV—A Toxic Relationship
Mpox should be added to the list of AIDS-defining diseases, investigators said. Those with poorly controlled HIV ...
FEBRUARY 22, 2023
Mpox Risks Among Cisgender and Pregnant Women Show Need for Education
A CDC report highlighted the risk for monkeypox (mpox) infection for cisgender and pregnant women, illustrating a ...
JANUARY 31, 2023
Mpox Vaccine Safe and Effective in Real-World Settings
Real-world data have shown that the monkeypox (mpox) modified vaccinia Ankara vaccine (Jynneos, Bavarian Nordic) is ...
JANUARY 10, 2023
